China Pharma Holdings, Inc. (CPHI) Stock Price & Analysis
China Pharma Holdings, Inc. (CPHI) closed at USD 0.66 on Friday, October 23, 2026, down 2.67% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.66; the Oct 23, 2026 session ranged USD 0.63–0.68 on volume of 164,190 shares. Market capitalization is —, with a 52-week range of USD 0.38–19.19 (ASE). Source: Nexqual, retrieved October 24, 2026 at 11:50 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CPHI.md
Key facts (CPHI)
- Last four reported quarters (through Jun 30, 2026): revenue $3.9M, net income -$4.5M (-114.3% margin) (SEC filings).
- Total return with dividends: 1Y -63.7% vs S&P 500 +13.4%; 5Y -99.8% vs S&P 500 +76.9%.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CPHI)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $9.6M | $8.1M | $7.0M | $4.5M | $4.1M | $3.9M |
| Gross profit | $349K | -$494K | -$281K | -$2.0M | -$132K | — |
| Operating income | -$2.9M | -$3.5M | -$2.8M | -$4.6M | -$3.2M | -$4.4M |
| Net income | -$3.4M | -$4.0M | -$3.1M | -$4.7M | -$3.2M | -$4.5M |
| EPS (diluted) | -$37.00 | -$37.80 | -$9.10 | -$2.71 | -$0.74 | — |
| Free cash flow | -$688K | -$812K | -$711K | -$444K | $89K | — |
| Gross margin | 3.6% | -6.1% | -4.0% | -43.8% | -3.2% | — |
| Operating margin | -29.7% | -43.8% | -39.2% | -101.3% | -78.2% | -111.8% |
| Net margin | -35.3% | -49.0% | -43.9% | -104.6% | -76.9% | -114.3% |
| Revenue growth | -11.3% | -15.9% | -13.5% | -35.4% | -8.5% | — |
| Cash + short-term investments | $4.9M | $2.0M | $1.4M | $627K | $345K | — |
| Total debt | $5.3M | — | — | — | — | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CPHI)
Total return (dividends reinvested) (CPHI)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -63.7% | -99.8% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -63.9% | -71.1% |
| Volatility (annualized) | 300.1% | 91.7% |
| Max drawdown | -92.1% (Jul 2026→Oct 2026) | -99.8% (Oct 2021→Apr 2026) |
CPHI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter (ends Mar 2012) | — | — | — | $0 | — |
| Current fiscal year (ends Dec 2011) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 11:50 UTC)
| Price | USD 0.66 |
|---|---|
| Change | ▼ 2.67% (down) |
| Previous Close | USD 0.66 |
| Open | USD 0.66 |
| Day Range | USD 0.63 – 0.68 |
| 52-Week Range | USD 0.38 – 19.19 |
| Volume | 164,190 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (CPHI)
Nexqual's technical model rates CPHI "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 11:50 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.98 (neutral) |
| vs SMA50 | Below (USD 0.8) |
| MACD | -0.03 (negative) |
Earnings (CPHI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2011-09-30 | USD 40 vs est 60 ▼ miss |
| 2011-03-31 | USD 50 vs est 57.5 ▼ miss |
| 2010-12-31 | USD 95 vs est 78.33 ▲ beat |
Source: Nexqual, October 24, 2026 at 11:50 UTC.
Financials & Fundamentals (CPHI)
| Total Revenue | $3.91M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -7.50% |
| Gross Margin | +11.76% |
| Operating Margin | -150.98% |
| Profit Margin | -114.33% |
| ROE | -20.99% |
| Debt / Equity | 0.11 |
| Current Ratio | 0.26 |
| Total Cash | $304,874 |
| Total Debt | $4.06M |
Source: Nexqual, October 24, 2026 at 11:50 UTC.
Ownership (CPHI)
| Insider Ownership | +89.63% |
|---|---|
| Institutional Ownership | +0.47% |
| Shares Outstanding | 43.02M |
| Float | 3.30M |
| Short % of Float | +0.20% |
Source: Nexqual, October 24, 2026 at 11:50 UTC.
From China Pharma Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-04-01)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SXTC | China SXT Pharmaceuticals, Inc. | USD 0.04 | ▼ 14.58% |
| CREG | Smart Powerr Corp. | USD 0 | ▼ 0% |
| ZNB | Zeta Network Group | USD 0.57 | ▼ 16.76% |
| BIMI | BIMI International Medical Inc. | USD 0 | ▲ 0% |
| CFOR | CapForce Inc. | USD 4.04 | ▲ 2.02% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 11:50 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt